# Getz Pharma

Organization · id `cardio:org-getz-pharma` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Getz+Pharma>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Getz Pharma
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus (`cardio:ct-nct04665284`)
- Sponsors: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver (`cardio:ct-nct04976283`)
- Sponsors: Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus (`cardio:ct-nct05161741`)
- Sponsors: Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study (`cardio:ct-nct05164263`)
- Sponsors: Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients (`cardio:ct-nct05167513`)
- Sponsors: Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus (`cardio:ct-nct05359432`)

## Provenance

Content hash: e00361eccb139d940e65246e2c2908035e61229b30c4f7359e1d43b7cefc0551
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
